John F. Paolini, CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA), sold 58,424 shares at $53.52 ($3.1M) on 2026-05-01, disclosed to the SEC on 2026-05-05.
Scheduled sale ($3.1M) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.52 | 37,327 | $2.0M | 63.7% |
| 2 | $54.04 | 21,097 | $1.1M | 36.3% |
| Total | $53.71 avg | 58,424 | $3.1M | 100% |
| Filing → |
| KNSA | SELL | 2025-08-08 | $1.9M | — | Filing → |
| KNSA | SELL | 2025-05-09 | $5K | — | Filing → |
| KNSA | SELL | 2024-09-04 | $3.1M | — | Filing → |